Order Article Reprints

Sanz Codina M, Gatti M, Troisi C, Fornaro G, Pasquini Z, Trapani F, Zanoni A, Caramelli F, Viale P, Pea F. Relationship between Pharmacokinetic/Pharmacodynamic Target Attainment and Microbiological Outcome in Critically Ill COVID-19 Patients with Documented Gram-Negative Superinfections Treated with TDM-Guided Continuous-Infusion Meropenem. Pharmaceutics. 2022; 14(8):1585. https://doi.org/10.3390/pharmaceutics14081585

Sanz Codina, Maria, Milo Gatti, Carla Troisi, Giacomo Fornaro, Zeno Pasquini, Filippo Trapani, Andrea Zanoni, Fabio Caramelli, Pierluigi Viale, and Federico Pea. 2022. "Relationship between Pharmacokinetic/Pharmacodynamic Target Attainment and Microbiological Outcome in Critically Ill COVID-19 Patients with Documented Gram-Negative Superinfections Treated with TDM-Guided Continuous-Infusion Meropenem" Pharmaceutics 14, no. 8: 1585. https://doi.org/10.3390/pharmaceutics14081585

Sanz Codina, M., Gatti, M., Troisi, C., Fornaro, G., Pasquini, Z., Trapani, F., Zanoni, A., Caramelli, F., Viale, P., & Pea, F. (2022). Relationship between Pharmacokinetic/Pharmacodynamic Target Attainment and Microbiological Outcome in Critically Ill COVID-19 Patients with Documented Gram-Negative Superinfections Treated with TDM-Guided Continuous-Infusion Meropenem. Pharmaceutics, 14(8), 1585. https://doi.org/10.3390/pharmaceutics14081585